Evidence map›Paper›PMID 34098591›Full record

ReviewMolecules and cells2021

An Impaired Inflammatory and Innate Immune Response in COVID-19.

Sung Ho Park

Registry-linked trialOpen access · diamondAbstract readReview
In one paragraph

Review in Molecules and cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06341374 (Impact of Sleep Disorders on Innate Immunity in COVID-19 Patients. A Cohort Study), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06341374 unknown statusnot on this mapstarted 2023, after this paper: background citation

Impact of Sleep Disorders on Innate Immunity in COVID-19 Patients. A Cohort Study

Typeobservational_patient_registrySponsorParc Taulí Hospital UniversitariRan2023 to 2024Enrolled50ConditionsApnea, Obstructive Sleep, SARS CoV 2 InfectionArmsInfluvac Tetra
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Review
  3. Meeting the Challenge of Controlling Viral Immunopathology.International journal of molecular sciences · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Sung Ho ParkDepartment of Biological Sciences, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, Korea.ORCID https://orcid.org/0000-0003-4856-7287
Ulsan National Institute of Science and Technology · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recent appearance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people around the world and caused a global pandemic of coronavirus disease 2019 (COVID-19). It has been suggested that uncontrolled, exaggerated inflammation contributes to the adverse outcomes of COVID-19. In this review, we summarize our current understanding of the innate immune response elicited by SARS-CoV-2 infection and the hyperinflammation that contributes to disease severity and death. We also discuss the immunological determinants behind COVID-19 severity and propose a rationale for the underlying mechanisms.

Indexed as

Anti-Inflammatory AgentsCOVID-19COVID-19 Drug TreatmentCytokine Release SyndromeDexamethasoneGene Expression RegulationHost-Pathogen InteractionsHumansImmunity, InnateInflammationInterferon Type IInterleukinsSARS-CoV-2Severe Acute Respiratory SyndromeSeverity of Illness IndexSignal TransductionAnti-Inflammatory AgentsDexamethasoneInterferon Type IInterleukinsCOVID-19cytokine stormimmunoparalysisinflammatory cytokinesinnate immune response

Identifiers

PMID34098591
PMCPMC8245320
OpenAlexW3166497326

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.